Introduction
============

Transforaminal epidural block (TFEB) is an effective diagnostic and treatment option for spinal radicular pain \[[@b1-yujm-2019-00122]\]. The transforaminal approach is target-specific, compared with other approaches for epidural blocks \[[@b2-yujm-2019-00122]\]. Potential risks associated with TFEB include infection \[[@b3-yujm-2019-00122],[@b4-yujm-2019-00122]\], dural puncture \[[@b5-yujm-2019-00122],[@b6-yujm-2019-00122]\], bleeding, and intravascular injection \[[@b5-yujm-2019-00122]\]. To reduce complications resulting from intravascular injection of drugs, several methods have been proposed, including use of short-beveled or blunt-type needles, large-diameter needles, non-particulate steroids, or imaging modalities such as real-time fluoroscopy (RTF) or digital subtraction angiography (DSA) \[[@b7-yujm-2019-00122]\]. There are no case reports or studies about fatal neurologic events resulting from intravascular injection of non-particulate steroids, but administration of local anesthetics may cause rare complications in the central nervous system during a cervical TFEB. Local anesthetics depress respiration and consciousness during a cervical root block \[[@b8-yujm-2019-00122]\]. Injection of a local anesthetic through a vertebral artery can cause loss of consciousness and seizures \[[@b9-yujm-2019-00122]\].

RTF reportedly failed to detect 29.0% of intravascular injections compared to DSA during lumbosacral TFEB \[[@b10-yujm-2019-00122]\]. However, Kim et al. \[[@b11-yujm-2019-00122]\] found no benefit with use of DSA compared to RTF during lumbosacral TFEB. DSA has disadvantages such as increased radiation exposure to the physician and patient and high cost of equipment compared to RTF \[[@b12-yujm-2019-00122]\]. DSA for TFEB was reported to increase the effective radiation dose by 2.3- to 4.3-fold compared to conventional fluoroscopy \[[@b13-yujm-2019-00122]\].

To our knowledge, no report has prospectively compared DSA and RTF during TFEB at the whole spine level, including cervical, thoracic, lumbar, and sacral levels, in the same patient.

The present study investigated whether DSA improved the detection rate for intravascular injection during TFEB at the whole spine level, compared to that using RTF.

Materials and methods
=====================

1. Patients and exclusion criteria
----------------------------------

The present study was approved by the Institutional Review Board of our hospital (DSMC 2015-09-042), and informed written consent was obtained from all participants.

We prospectively examined 316 TFEB procedures. Inclusion criteria were age over 18 years and radicular pain from herniated nucleus pulposus, spinal stenosis, post-spinal surgery syndrome; zoster-induced pain; or pain owing to other conditions such as complex regional pain syndrome. Exclusion criteria were pregnancy, allergy to contrast medium and local anesthetics, participant refusal, and persistent contraindication to epidural block such as coagulopathy and infection at the injection site.

2. Intervention and data collection
-----------------------------------

Two pain-management physicians were involved in this study. Both physicians were board-certified in the department of pain medicine, and had more than 8 years of working experience. TFEB was performed by one physician and simultaneously observed by the other physician.

Before the procedure, all participants were monitored with an electrocardiogram, pulse oximetry, and noninvasive blood pressure measurement. A 20- or 22-G cannula was inserted in the hand. The participants did not receive sedation. Under fluoroscopic guidance, TFEB was performed using a Quincke type, 25-G, 9-cm spinal needle (Taechang Industrial Co., Kongju, Korea). For cervical level injection, the participant was placed in a supine position on a table with the head slightly extended. The fluoroscope (Ziehm Vision, Ziehm Imaging, Nuremberg, Germany) was rotated obliquely 45-55° to the ipsilateral side to provide the best view of the selected neural foramen. The needle was advanced to the superior articular process, at the division between the caudal third and middle third. The needle was then advanced into the neural foramen, touching its posterior border to the halfway point between the medial and lateral borders of the articular pillars in an anteroposterior (AP) view. For thoracic level injection, the participant was placed in prone position. The fluoroscopic beam was aligned perpendicular to the vertebral endplates in an AP view and then rotated to a 10-20° oblique angle towards the side being injected. The needle was advanced from a point between the lateral margin of the pedicle and the medial aspect of the rib head to the posterior surface of the vertebral body using tunnel vision technique. For lumbar injections, the participant was placed in prone position. The fluoroscope was tilted in the caudocephalad direction to align parallel with the endplates in an AP view. The fluoroscope was rotated to a 20-30° oblique angle toward the side being injected, to bring the "Scotty dog" appearance of the spine into view. The needle was advanced into the neural foramen at a point just below the \"chin\" of the "Scotty dog" with tunnel vision technique. For sacral injections, the participant was placed in prone position. The fluoroscope was tilted in the caudocephalad direction to align parallel with the L5 inferior endplate and the S1 superior endplate in an AP view. The needle was advanced to the superior lateral quadrant of the neural foramen.

After confirmation of final needle position using biplanar fluoroscopy, 2 mL of nonionic contrast medium (Omnipaque 300, GE Healthcare, Little Chalfont, Buckinghamshire, UK) was injected at a rate of 0.5 mL/s under RTF; 30 s later, another 2 mL of nonionic contrast medium was injected at a rate of 0.5 mL/s under DSA. Intravascular injection was defined as contrast medium spreading out through the vascular channel during injection under RTF and DSA. If intravascular injection was observed, the needle position was changed. A total of 2 mL of 0.5% lidocaine mixed with dexamethasone 5 mg was injected after intravascular injection was ruled out.

3. Sample size
--------------

In a previous study, the incidence of intravascular injection during TFEB at the whole spine level was 10.5% \[[@b14-yujm-2019-00122]\]. We considered a 50% increase in the incidence of intravascular injection to be clinically important. The sample size was estimated with the requirement of \<0.05 and \<0.2 Type I and II error rates, respectively. Considering a 10% dropout rate, 316 TFEB cases in each group was required. A flow diagram of this study design is shown in [Fig. 1](#f1-yujm-2019-00122){ref-type="fig"}.

4. Statistical analysis
-----------------------

Data on the age, sex, diagnosis, spinal level, and procedure side were collected. The data were analyzed with McNemar\'s test, using SAS software version 9.3 (Cary, NC, USA). The influence of factors associated with intravascular injection during TFEB was examined using logistic regression analysis, and the adjusted odds ratio (OR) and 95% confidence interval (CI) were also calculated. A *p*-value \<0.05 was considered statistically significant.

Results
=======

In total, 316 TFEB treatments were performed, with 56 injections (17.7%) at cervical levels, 31 (10.0%) at thoracic levels, 135 (42.7%) at lumbar levels, and 94 (29.7%) at sacral levels. There were no complications associated with TFEB. The 316 TFEB treatments were performed in 218 enrolled participants, with a mean age of 62.1 years. The characteristics of study participants are presented in [Table 1](#t1-yujm-2019-00122){ref-type="table"}. TFEB treatments were performed from C3 to S2 spinal levels.

The incidence of intravascular injection at each level detected with DSA and RTF is presented in [Table 2](#t2-yujm-2019-00122){ref-type="table"}. Thirty-six intravascular injections (12 \[21.4%\] at cervical, 2 \[6.5%\] at thoracic, 11 \[8.1%\] at lumbar, and 11 \[11.7%\] at sacral levels) were detected, for an overall intravascular injection rate of 11.4% using RTF. Forty-five intravascular injections (14 \[25%\] at cervical, 3 \[9.7%\] at thoracic, 14 \[10.4%\] at lumbar, and 14 \[14.9%\] at sacral levels) were detected, for an overall intravascular injection rate of 14.2% using DSA. The intravascular injection detection rate using DSA was statistically different from that using RTF (*p*=0.004). All intravascular injections detected using RTF were also observed using DSA. RTF missed 9 cases of intravascular injection (2 at cervical, 1 at thoracic, 3 at lumbar, and 3 at sacral levels) that were detected using DSA (RTF sensitivity, 80.0%).

[Table 3](#t3-yujm-2019-00122){ref-type="table"} shows the adjusted OR and 95% CI for each variable during intravascular injection using DSA. Only the spinal level showed a significant association with intravascular injection. The incidence of intravascular injection was significantly higher at the cervical level than at the thoracic (*p*=0.009) and lumbar (*p*=0.011) levels. Patient age, sex, height, weight, procedure side, and diagnosis had no effect on the incidence.

Discussion
==========

Our results indicate that intravascular injection was sequentially detected using RTF and DSA during TFEB at the whole spine level. The overall incidence of intravascular injection was 14.2% using DSA and 11.4% using RTF. Nine intravascular injections were missed (2 at cervical, 1 at thoracic, 3 at lumbar, and 3 at sacral levels) with RTF compared to DSA. A 25% improvement was observed using DSA compared to RTF. Therefore, DSA had a better detection rate for intravascular injection during TFEB.

DSA is a radiological technique that can be used to clearly visualize and distinguish blood vessels from surrounding tissues; this is done by subtracting the pre-contrast image from the post-contrast injection image \[[@b12-yujm-2019-00122],[@b15-yujm-2019-00122]\]. Visnjevac et al. \[[@b16-yujm-2019-00122]\] reported the efficacy of DSA in detection of intravascular penetration compared with RTF during TFEB in a recent meta-analysis. They included 1,290 TFEB cases (3.2% at cervical, 76.3% at lumbar, and 20.5% at sacral levels) and demonstrated that DSA showed a 32% improvement in detection of intravascular penetration during TFEB, compared to that using RTF. However, only 3.2% of cases in their study were performed at cervical levels and did not include any thoracic cases. Therefore, their study could not represent TFEB at the whole spine level. In contrast, the present study attempted to include more cervical and thoracic TFEB cases (17.7% at cervical and 10.0% at thoracic levels).

Even though previous studies demonstrated DSA to be superior to RTF for vascular detection during TFEB, McLean et al. \[[@b15-yujm-2019-00122]\] indicated that the main vascular uptake observed using DSA was attributed to venous uptake and that DSA did not increase the detection rate of arterial uptake. Moreover, in the study of Lee et al. \[[@b10-yujm-2019-00122]\], DSA did not successfully distinguish between arterial and venous injections.

Using RTF, Nahm et al. \[[@b14-yujm-2019-00122]\] conducted a large prospective study to evaluate the risk factors associated with intravascular injection in TFEB. They evaluated 2,145 injections performed on 1,088 patients and found a significant difference between cervical (20.6%) and sacral (16.5%) level injections and between lumbar (6.1%) and thoracic (8.2%) level injections. They also found no association between intravascular injection during TFEB and patient characteristics such as age, sex, body mass index, and diagnosis. No prior report has investigated the risk factors associated with intravascular injection using DSA at the whole spine level under various conditions. In the present study, the spinal procedure level was the only significant association identified, consistent with the results of a previous study using RTF \[[@b14-yujm-2019-00122]\]. The cervical level (25%) showed a significantly higher intravascular injection rate than the thoracic (9.7%) and lumbar (10.4%) levels.

The present study also found no difference in intravascular injection rates during TFEB according to the diagnosis, consistent with the results of a previous study using RTF \[[@b11-yujm-2019-00122],[@b14-yujm-2019-00122]\]. We also found no differences in intravascular injection rates between DSA and RTF according to diagnosis.

In this study, we used a Quincke needle which is sharp. Because blunt needles will displace and not penetrate vessels owing to their dull tip \[[@b17-yujm-2019-00122],[@b18-yujm-2019-00122]\], the use of blunt needles during TFEB has been suggested to avoid intravascular injection of steroids \[[@b7-yujm-2019-00122],[@b19-yujm-2019-00122]\]. Animal studies have shown a reduced incidence of arterial puncture and bleeding with the use of blunt needles compared to that using sharp needles \[[@b17-yujm-2019-00122],[@b18-yujm-2019-00122]\]. Several studies have found that use of blunt needles during lumbar TFEB could reduce intravascular injections and paresthesia compared to those using sharp needles \[[@b20-yujm-2019-00122]-[@b22-yujm-2019-00122]\]. However, Smuck et al. \[[@b23-yujm-2019-00122]\] failed to find any benefit with use of blunt needles during lumbosacral TFEB compared to that using sharp needles. This issue remains controversial, and further study is needed to determine whether the use of blunt needles could reduce intravascular injections during TFEB.

Intravascular injection was sequentially detected using RTF and DSA guidance in the present study. This study had some limitations. First, the procedural physician was not blinded to the type of imaging modality used to detect intravascular injection. To minimize confirmation bias and provide homogeneous procedural conditions for TFEB, the same procedural physician performed all 316 injections. Second, RTF and DSA were successively used in the same patient during TFEB. Intravascular injections detected by RTF were also detected by DSA. However, the injected contrast medium and extravasation of blood from intravascular penetration during RTF observation may have affected the detection of intravascular injection during DSA observation. Third, it may be impossible to define a vascular contrast spreading pattern as venous or arterial during epidural TFEB because these patterns were ambiguous despite the use of DSA \[[@b24-yujm-2019-00122],[@b25-yujm-2019-00122]\]. We also could not differentiate between the two vascular patterns. Fourth, the proportions of cervical, thoracic, and lumbar levels in TFEB differed, as these reflected the distribution of patients with spinal pain in the pain clinic. Fifth, structural differences according to vertebral levels or individual spinal disease could affect the results, but further studies are needed to clarify this.

During TFEB at the whole spine level, DSA showed a better detection rate than RTF for intravascular injection. Special attention is recommended for cervical TFEB, which showed an intravascular injection rate that was significantly higher than that at other levels.

No potential conflicts of interest relevant to this article was reported.

![Flow diagram of the study design. DSA, digital subtraction angiography; RTF, real-time fluoroscopy.](yujm-2019-00122f1){#f1-yujm-2019-00122}

###### 

Characteristics of 316 injections performed in 218 participants

  Variable                         Value
  -------------------------------- -------------
  Age (yr)                         62.14±12.23
  Height (cm)                      161.81±8.32
  Weight (kg)                      61.70±9.83
  Sex (male/female)                155/161
  Site of injection (right/left)   157/159
  Level                            
   Cervical                        56
   Thoracic                        31
   Lumbar                          135
   Sacral                          94
  Diagnosis                        
   Herniated nucleus pulposus      87
   Spinal stenosis                 166
   Post-spinal surgery syndrome    21
   Zoster-induced pain             31
   Others                          12
  Total                            316

Values are presented ad mean±standard deviation or number (proportion).

###### 

Incidence of intravascular injections during transforaminal epidural block

                                       Number of intravascular injections on DSA (%)                 Number of intravascular injections on RTF (%)
  ------------------------------------ ------------------------------------------------------------- -----------------------------------------------
  Sex (n)                                                                                            
   Male (155)                          21 (13.5)                                                     17 (11.0)
   Female (161)                        24 (14.9)                                                     19 (11.8)
  Level of injection (n)                                                                             
   Cervical (56)                       14 (25.0)                                                     12 (21.4)
   Thoracic (31)                       3 (9.7)                                                       2 (6.5)
   Lumbar (135)                        14 (10.4)                                                     11 (8.1)
   Sacral (94)                         14 (14.9)                                                     11 (11.7)
  Side of injection (n)                                                                              
   Right (157)                         22 (14.0)                                                     18 (11.5)
   Left (159)                          23 (14.5)                                                     18 (11.3)
  Diagnosis (n)                                                                                      
   Herniated nucleus pulposus (87)     10 (11.5)                                                     9 (10.3)
   Spinal stenosis (166)               25 (15.1)                                                     19 (11.4)
   Post-spinal surgery syndrome (21)   5 (23.8)                                                      5 (23.8)
   Zoster-induced pain (31)            3 (9.7)                                                       2 (6.5)
   Others (12)                         2 (16.7)                                                      1 (8.3)
  Total (316)                          45 (14.2)^[a)](#tfn3-yujm-2019-00122){ref-type="table-fn"}^   36 (11.4)

Values are presented as number (%).

DSA, digital subtraction angiography; RTF, real-time fluoroscopy.

*p*\<0.05 compared with RTF.

###### 

OR and 95% CI of variables on intravascular penetration using DSA

  Variable                        OR                                                       95% CI
  ------------------------------- -------------------------------------------------------- ------------
  Sex                                                                                      
   Male                           1.00                                                     \-
   Female                         1.26                                                     0.90-1.82
  Age                             0.99                                                     0.96-1.01
  Height                          1.00                                                     0.97-1.04
  Weight                          1.02                                                     0.99-1.05
  Side of injection                                                                        
   Right                          1.00                                                     \-
   Left                           0.94                                                     0.50-1.76
  Level                                                                                    
   Cervical                       2.88^[a)](#tfn5-yujm-2019-00122){ref-type="table-fn"}^   1.27-6.54
   Thoracic                       0.93                                                     0.25-3.44
   Lumbar                         1.00                                                     \-
   Sacral                         1.51                                                     0.69-3.34
  Diagnosis                                                                                
   Herniated nucleus pulposus     1.21                                                     0.31-4.73
   Spinal stenosis                1.66                                                     0.47-5.86
   Post-spinal surgery syndrome   3.11                                                     0.65-14.85
   Zoster-induced pain            1.87                                                     0.27-12.85
   Others                         1.00                                                     

OR, odds ratio; CI, confidence interval; DSA, digital subtraction angiography.

*p*\<0.05 compared with thoracic and lumbar level.
